Code intelligence

FDA-NDA019981 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code FDA-NDA019981.

Critical code risk

Signal breakdown

1 shown · 1 total in platform

Risk: Critical

Critical

100%

High

Routine

Low

New this month

alerts added in last 30 days

Effective soon

—

no upcoming deadlines

FDA Approval: ULTRATAG RBC (KIT FOR THE PREPARATION OF TECHNETIUM TC 99M RED BLOOD CELLS) — Type 3 - New Dosage Form

Policy FDA-NDA019981 · Radiology

Critical

ULTRATAG RBC is an injectable technetium Tc 99m red blood cell labeling kit approved for intravenous administration, placing it squarely in the Medicare Part B billing pathway as a physician-administe

View alert

Audit documentation

Building an audit file that includes FDA-NDA019981?

The Tripwire Audit Pack exports 12 months of Radiology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Radiology audit pack — $349One-time purchase · not a subscription